Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Sep 12.
Published in final edited form as: Int J Gynecol Cancer. 2021 Mar 4;31(5):647–655. doi: 10.1136/ijgc-2020-002315

Development of a Surgical Competency Assessment Tool for Sentinel Lymph Node Dissection by Minimally Invasive Surgery for Endometrial Cancer

Kristen MOLONEY 1, Monika M JANDA 2, Michael FRUMOVITZ 3, Mario LEITAO Jr 4, Nadeem ABU-RUSTUM 4, Emma ROSSI 5, James L NICKLIN 6, Marie PLANTE 7, Fabrice LECURU 8, Alessandro BUDA 9, Andrea MARIANI 10, Yee LEUNG 11, Sarah E FERGUSON 12, Rene PAREJA 13, Rainer KIMMIG 14, Pearl Shuang Ye TONG 15, Orla MCNALLY 16, Naven CHETTY 17, Kaijiang LIU 18, Ken JAABACK 19, Julio LAU 20, Joseph NG 21, Henrik FALCONER 22, Jan PERSSON 23, Russell P LAND 6, Fabio MARTINELLI 24, Andrea GARRETT 1, Alon D ALTMAN 25, Adam PENDLEBURY 26, David CIBULA 27, Roberto ALTAMIRANO-ASSAD 28, Donal BRENNAN 29, Thomas IND 30, Cornelis D DE KROON 31, Ka Yu TSE 32, George B HANNA 33,*, Andreas OBERMAIR 34,*
PMCID: PMC9465805  NIHMSID: NIHMS1830789  PMID: 33664126

Abstract

Introduction:

Sentinel lymph node dissection is widely utilized in staging of endometrial cancer. Variation in surgical technique potentially impacts diagnostic accuracy and oncologic outcomes and poses barriers to comparison of outcomes across institutions or clinical trial sites. Standardization of surgical technique and surgical quality assessment tools are critical to the conduct of clinical trials. By identifying mandatory and prohibited steps of sentinel lymph node dissection in endometrial cancer, the purpose of this study was to develop and validate a competency assessment tool for use in surgical quality assurance.

Methods:

A Delphi methodology was applied, included thirty-five expert gynecological oncology surgeons from sixteen countries. Interviews identified key steps and tasks which were rated mandatory, optional or prohibited using questionnaires. Using the surgical steps for which consensus was achieved, a competency assessment tool was developed and subjected to assessments of validity and reliability.

Results:

Seventy percent (70%) consensus agreement standardized the specific mandatory, optional and prohibited steps of sentinel lymph node dissection for endometrial cancer and informed development of a competency assessment tool. Consensus agreement identified twenty-one mandatory and three prohibited steps to complete a sentinel lymph node dissection. The competency assessment tool was used to rate surgical quality in three preselected videos, demonstrating clear separation in the rating of the skill level displayed with mean skills summary scores differing significantly between the three videos (F score = 89.4; p<0.001). Internal consistency of the items was high (Cronbach α = 0.88).

Conclusion:

Specific mandatory and prohibited steps of sentinel lymph node dissection in endometrial cancer have been identified and validated based on consensus amongst a large number of international experts. A competency assessment tool is now available and can be used for surgeon selection in clinical trials and for ongoing, prospective quality assurance in routine clinical care.

Keywords: Sentinel Node Dissection, Endometrial cancer, Surgical Quality Assurance

INTRODUCTION

Surgical trials pose methodological challenges(1) because surgeon training, experience, and skills influence delivery of surgical interventions, leading to variability in health practices and outcomes(2). Surgical quality assurance can aid adherence to pre-defined standards and outcome measures and enable reliable comparison across multiple clinical trial sites(37).

Management guidelines for apparent uterine-confined disease prescribe total hysterectomy, bilateral salpingo-oophorectomy for removal of the primary tumour and assessment of locoregional lymph nodes to establish the stage of disease (‘staging’)(8). This information is prognostic and may guide postoperative treatment decisions(8, 9). Historically, surgical staging entailed full or limited pelvic/paraaortic lymph node dissection. This practice was informed by results of observational, clinicopathologic studies(10, 11) then adopted by FIGO in 1988(12). Subsequent prospective studies failed to demonstrate differences in survival outcomes(13, 14). Contemporary surgical staging involves sentinel lymph node dissection (15). According to the sentinel lymph node (SLN) concept, tumour cells metastasise to one or two lymph nodes first, before involving further lymph nodes(16). Presumed benefits of sentinel lymph node dissection include increased surgical staging precision, whilst sparing removal of other regional lymph nodes(17). Sentinel nodes are examined histopathologically using immunohistochemical ultrastaging(18). Sentinel lymph node dissection obtains accurate information about lymph node status(18) such that many clinicians now elect it in place of a full lymphadenectomy(19).

With rapid and global adoption of sentinel lymph node dissection (19) comes variability of surgical technique. Local institutional guidelines have been developed to minimize variation in outcomes(20). However, these algorithms are insufficient to facilitate harmonization of the detailed surgical technique across a group of surgeons. There remains a need to define the precise surgical steps required to accomplish satisfactory bilateral sentinel lymph node dissection; assess a surgeon’s proficiency before enrolment of patients into clinical trials; and assist with ongoing surgical quality assurance(21).

The purpose of this study was to establish a consensus on the specific mandatory and prohibited steps of sentinel lymph node dissection in endometrial cancer, as well as develop a competency assessment tool. This facilitates assessment of surgical quality in clinical trials aiding in both selection of surgeons and prospective Quality Assurance.

METHODS

Study participants

The study was approved by the institutions Human Research Ethics Committee and informed written and/or eConsent was obtained from all participants. Participants were expert gynecological oncology surgeons from five continents currently performing sentinel lymph node dissection, henceforth referred to as “the group”. Experts were recruited using snowball sampling, i.e. first contacting surgeons known to perform sentinel lymph node dissection per scientific reports or presentations in peer reviewed forums, and then asking these surgeons to nominate other experts. Participant characteristics were summarized using descriptive statistics.

Standardization of Sentinel Lymph Node Dissection

A four-round Delphi methodology was applied in order to achieve standardization of sentinel lymph node dissection steps and tasks. Several rounds of questionnaires were sent out to experts with the responses then aggregated, de-identified and shared with the group after each round. Experts adjusted their answers in subsequent rounds, based on their interpretation of the group response provided to them. Over multiple rounds of questionnaires, the Delphi method seeks to reach best response through consensus(22). Study data was collected and managed on a secure, web-based REDCap electronic database hosted at The University of Queensland(23, 24).

Delphi Consensus Process and Hierarchical Task Analysis

Round one (semi-structured interviews):

After providing written informed consent, interviewees described their opinion about the mandatory, optional and unwarranted steps taken in performing sentinel lymph node dissection for endometrial cancer. The interviews were conducted individually and were audio recorded. Recordings were transcribed and thematically analysed by two reviewers (KM, AO). Each reviewer independently identified important and recurring codes (e.g. uterine manipulation, identifying anatomy, trouble shooting). Codes were then compared to confirm important themes. The reviewers jointly examined codes and themes and interpreted the data. Where discordance in coding was identified, themes were refined through discussions between the two reviewers. Interviews were conducted until saturation in variations of technique. Key steps and tasks of sentinel lymph node dissection were identified by a process of hierarchical task analysis.

Round two-to-four (consensus process):

An initial questionnaire was devised including all of the variations identified in the interviews. Members of the group were invited to indicate their agreement or disagreement with variations. In accordance with other published work (25), consensus agreement level was set at 70% (4, 26). Variations where consensus was reached were iteratively moved into an operation guide; those with <70% agreement remained for a subsequent survey round. In accordance with the journal’s guidelines, we will provide our data for the reproducibility of this study in other centers if such is requested.

Operation Guide

A sentinel lymph node dissection operation guide was created including the mandatory, optional and prohibited/unwarranted steps that reached 70% agreement level.

Competency Assessment Tool

Development

The final competency assessment tool was limited to mandatory and prohibited steps in the intraoperative phase of sentinel lymph node dissection. A score of one to four was allocated to each step – ‘skillful’, ‘adequate’, ‘inconsistent’, ‘lacking/deficient’; for troubleshooting steps ‘not applicable’ was also offered.

Content validity

Three surgical videos were selected having been agreed by KM and AO to represent poor, inconsistent or optimal technique of sentinel lymph node dissection according to the ratings conferred by application of the competency assessment tool. The videos featured the 11 surgical steps of sentinel lymph node dissection assessed by the competency assessment tool, but did not include tracer preparation and injection, surgical trouble shooting or pathological assessment of tissues. Content validity was assessed by KM and AO who discussed each step of the competency assessment tool in detail, before watching those individual steps performed with various skill levels across the three surgical videos, confirming that competency assessment tool items adequately reflected the skill required.

Contrast validity and internal reliability

Contrast validity(27) was assessed via invitation of the group members to utilize the competency assessment tool in rating the three pre-selected videos, each representing distinct performance levels. Due to the occurrence of some cells with a cell size <5, Fisher’s exact tests were performed to assess if the proportion of experts who rated each of the three videos as ‘skillful’, ‘adequate’, ‘inconsistent’, ‘lacking/deficient’ differed according to the quality of the video. An average competency assessment tool score (possible range 11–44) was computed for each video. One-way ANOVA modelling determined if the overall competency assessment tool score assigned by the sentinel lymph node dissection experts to each video differed significantly. The summary score was used to assess the internal consistency (Cronbach alpha) of the competency assessment tool.

RESULTS

Thirty-five international gynecological oncology surgeons and experts in sentinel lymph node dissection from 16 countries participated. Some demographic data was not available for five participants, but 28 surgeons were above 40 years of age (80%) and 27 were male (77%) (Table 1).

Table 1:

Participating surgeons demographic characteristics

Variables n= 351 (%)
Age (years) 31–41 4 (11)
41–50 15 (43)
51–60 14 (40)
>61 1 (3)
Gender Female 8 (23)
Male 27 (77)
Continent Europe 10 (29)
North America 9 (26)
Australia 10 (29)
Asia 4 (11)
South America 2 (6)
Does your Institution have its own sentinel node mapping protocol in endometrial cancer? No 14 (40)
Yes 19 (54)
How did you learn to perform sentinel node biopsies? Self-taught 16 (46)
Learned from research papers 15 (43)
Standard operating procedures/protocols 11 (31)
Taught by senior colleague/s 11 (31)
Videos 10 (29)
Trained by surgeon/s overseas 7 (20)
Formal course/s 4 (11)
Other 7 (20)
How many years gynonc? (years) Less than 10 11 (31)
10–19 14 (40)
20–29 9 (26)
30 or more 1 (3)
How many years performed SLND 2 ? (years) Less than 5 13 (37)
5–9 8 (23)
10 or more 11 (31)
Number of SLND 2 Less than 50 14 (40)
50–99 10 (29)
100 or more 6 (17)
1

Not all 35 participants provided data on demographics

2

Sentinel Lymph Node Dissection

Twenty-four surgeons had practiced gynecological oncology for more than 10 years (69%), and 21 had performed sentinel lymph node dissection for more than five years (60%). Nineteen surgeons (54%) reported that their institution had an endometrial cancer sentinel lymph node dissection standard protocol. Twenty-one surgeons (60%) performed more than 50 sentinel lymph node dissections annually, excluding those performed for cancer of the vulva. Participating surgeons reported using between one and eight methods to learn sentinel lymph node dissection; e.g. being self-taught (46%), learning from research papers (43%) or being trained by a senior colleague (31%).

Standardization of Sentinel Node Dissection

Delphi Round One (Hierarchical Task Analysis)

Saturation in variation of sentinel lymph node dissection technique was reached after 25 interviews. Analysis of transcripts allocated themes into four phases: preoperative (dye selection and preparation, injection); intraoperative (pelvic dissection, identification of key anatomical structures, definition and dissection of sentinel node, extraction of tissue); trouble shooting; and a postoperative (pathology) phase. Task variations were defined as management of specific surgical steps in different ways. In total 107 task variations were identified across the interviews (Table 2).

Table 2:

Hierarchical task analysis including task variations

Phase Theme Sub-themes No. of sub tasks/task variations
Peri-operative Tracer Injection Choice of tracing agent
Site of injection
Tracer Concentration
Total volume of injected
Injection technique
34
Uterine Manipulation Use of manipulator at all
Timing of manipulator insertion
Type of uterine manipulator
9
Sequence of Initial Steps Timing of entry
Timing of adhesiolysis
Timing of staging inspection
7
Operative Preparation/opening spaces Transperitoneal identification of channels Pelvic Side wall spaces 10
Identifying anatomy, lymphatic channels and sentinel nodes Anatomical structure
Methods of locating nodes
24
Excision and confirmation of mapped nodes Defining the SLN
Technique of nodal excision
Mode of ex vivo SLN confirmation
7
Specimen retrieval Mode of containment 5
Troubleshooting Action plan for no nodes mapped 5
Post-Operative Specimen labelling Anatomical site
Laterality
4
Pathology processing 2

Delphi Rounds Two – Three (Consensus Process)

The first survey (Delphi round two) featured 107 task variations and was completed by all 35 participants (Supplementary Table 1). The second survey (Delphi round three) was informed by the results of the first survey and 33 of 35 participants responded (Supplementary Table 2). Over rounds two and three, >70% consensus was achieved in 33 of the 107 (30.8%) task variations(4, 26) on mandatory, optional and prohibited steps of sentinel lymph node dissection. Of the variations that reached consensus, 21 were classified as mandatory, nine optional and three prohibited. For example, in round two, 79% of participants agreed that “a transperitoneal approach of injecting dye into the uterus” should be prohibited; while 75% of participants agreed that “the internal iliac artery must be identified for sentinel node mapping” was mandatory. An operation guide consisting of the final list of steps for which consensus was obtained is provided in Table 3.

Table 3: Operation Guide.

Final consensus on mandatory and prohibited steps of SLND by minimally invasive surgery in Endometrial Cancer.

Surgical Step Descriptor Consensus recommendation

Tracer ICG Mandatory

Blue Dye Optional

Radio-labelled technetium Optional

Injection location Ectocervix in two or four positions Mandatory

Injection technique Superficial injection into the ectocervix Mandatory
Transperitoneal injection into the uterus Prohibited
Hysteroscopic injection into the uterus Prohibited
Surgeon appreciation of resistance at tracer injection Mandatory

Injection needle Gauge between 20G and 25G Mandatory
Length sufficient to ensure easy and accurate access to the cervix Mandatory

Uterine manipulator If being used, insert uterine manipulator after tracer injection Mandatory

White light inspection Prior to SLN mapping, conduct an inspection of the pelvic areas Mandatory

Round ligament & Infundibulopelvic ligament Preserve Optional

Divide Optional

External vessels Identify the external iliac vessels Mandatory

Internal iliac artery Identify the internal iliac artery Mandatory

Ureter Identify the ureter Mandatory

Obliterated umbilical ligament Identify the obliterated umbilical ligament Mandatory

Uterine artery Identify the uterine artery (medial to the ureter) Optional

Paravesical space Open the paravesical space Mandatory

Direction of dissection Start sentinel lymph node mapping at the level of the uterine artery and continue dissection LATERALLY away from the uterus Mandatory

Start sentinel lymph node mapping at the level of the uterine artery and and continue MEDIALLY towards the uterus Optional

Start sentinel lymph node mapping at the level of the uterine artery and and continue towards the pre-sacral area Optional

Start sentinel lymph node mapping at the most highlighted node and dissect proximally (TOWARDS cervix) Optional

Start sentinel lymph node mapping at the most highlighted node and dissect cephalad (AWAY from cervix) Optional

Dissection technique Use blunt or electrosurgical technique Mandatory
Avoid disrupting lymphatic channels during dissection Mandatory
Ensure isolation of node from local anatomy Mandatory

Definition of the Sentinel Node A sentinel node is defined as …
 • The most proximal node1, irrespective of the nodal station in which the node is found Mandatory
 • A single mapped node or a single node plus its next station echelon node(s). Mandatory

SLN dissection SLN dissection should be completed in one hemipelvis before proceeding to the contralateral side Mandatory

Troubleshooting Troubleshooting when no nodes are mapping includes any one, or combination of, the following OPTIONS: Mandatory
 • Wait; undertake dissection on the contralateral side before returning to original side
 • Extend retroperitoneal dissection to encompass common, pre-sacral and/or paraaortic areas
 • Re-inject ICG
 • Undertake a side-specific lymphadenectomy

Specimen extraction Removal of nodes without using a containment device Prohibited

Prove of sentinel node Use ex-vivo green fluorescence to prove the sentinel node Mandatory

Specimen labelling Label specimens according to laterality (right/left) AND nodal station (obturator/external iliac/internal iliac/presacral/common iliac/aortic/caval) Mandatory

Ultrastaging Use enhanced pathology techniques, such as immunohistochemistry, for ultrastaging of sentinel nodes Mandatory
1

The most proximal node is defined as the node closest to the uterus, regardless of location.

There was consensus that the tracer of choice must be indocyanine green (ICG) but adding other tracers is optional. There was consensus that ICG should be administered by superficial injection (1–2 mm) into the cervix. Superficial injection was defined by the group as sub-mucosal injection into the epithelium of the ectocervix (akin to intra-dermal injection techniques used in sentinel lymph node mapping for vulvar cancer). Deep injection (1 cm) was considered optional only when combined with mandatory superficial injection. Deep injection alone was considered prohibited by consensus. There was no consensus about the dilution of ICG (between 0.5 mg/l and 1.5 mg/ml), the total volume injected or timing of injection (before or after establishing a pneumoperitoneum). The use of a uterine manipulator was considered optional, but if used, it should be inserted after tracer injection. There was consensus that dividing the round ligament and the infundibulopelvic ligament can be performed either before or after sentinel lymph node dissection. The pelvic structures and spaces that should be demonstrated for sentinel lymph node dissection include external and internal iliac vessels, ureter, obliterated umbilical ligament and the paravesical space. The direction of the sentinel lymph node dissection was considered optional (starting close to the cervix or dissecting towards the cervix).

The group agreed that the sentinel node should be defined as the most proximal node irrespective of the nodal station in which the node is found. Eighteen participants felt that mapping of presacral nodes should be optional (56.3%). There was lack of consensus on a side-specific lymphadenectomy if no nodes are mapped on one side. Participants agreed that the sentinel node should be a single mapped node with or without its next station (second echelon node(s)). A majority of participants (59.4%) but less than required for consensus, agreed that not all second, third and fourth echelon nodes should be removed. Greater than seventy percent of participants agreed that specimen extraction should be within a containment device. There was consensus that ex-vivo fluorescence should be used to prove the sentinel node; that labelling of the sentinel node should be according to laterality and nodal station; and enhanced pathology techniques for ultrastaging of sentinel nodes should be used.

Contrast validity and internal reliability:

Twenty-seven (77.1%) Delphi participants were involved in rating the quality of surgery of the three preselected videos using the competency assessment tool (Figure 1). For each of the 10 initial surgical steps, there was clear separation in the rating of the skill level displayed between the three videos (Table 4).

Figure 1:

Figure 1:

SLND Competency Assessment Tool

Table 4:

Assessment of contrast validity

Poor Video Inconsistent Video Optimal Video Fishers exact test
White light inspection 1 (4) 6 (22) 22 (81) 47.1; p<0.00
External vessels 0 (0) 5 (19) 21 (78) 56.0; p<0.001
Internal iliac artery 0 (0) 2 (7) 22 (82) 75.3; p<0.001
Ureter 0 (0) 6 (22) 20 (74) 70.6; p<0.001
Paravesical space 0 (0) 4 (15) 19 (70) 58.9; p<0.001
Obliterated umbilical ligament 0 (0) 2 (7.4) 19 (70) 60.3; p<0.001
Dissection technique 1 (4) 2 (7.4) 16 (59) 36.9; p<0.001
Proof of sentinel node 6 (22) 2 (7.4) 20 (74) 33.6; p<0.001
Specimen extraction 0 (0) 9 (33) 21 (78) 84.2; p<0.001
SLN mapping 1 (3.7) 5 (19) 10 (37) 15.9; p=0.03

n (%) of reviewers who rated the performance as skilful

For example, while 78% of experts rated the “optimal technique video” as skillfully performing the dissection of the iliac vessels, only 19% and 0% of experts rated the “inconsistent technique video” and “poor technique video” as skillful (Fishers exact test = 56.0; p<0.001). For the last step (“completion of SLND in one hemipelvis before proceeding to the contralateral side”), 25 of the 27 group members rated this step as not applicable. Overall, the mean skills summary score differed significantly between the three videos from 35.6 (SD =4.7) for the “optimal technique video”, to 25.3 (SD=5.9) for the “inconsistent technique video” and 17.7 (SD=4.1) for the “poor technique video” (One-way ANOVA F score = 89.4; p<0.001). Internal consistency of the items was high (Cronbach α = 0.88).

DISCUSSION

Summary of Main Results

We report the creation of a competency assessment tool, derived by consensus amongst a large number of international experts, outlining the mandatory, optional and prohibited steps of a sentinel lymph node dissection procedure for endometrial cancer. The competency assessment tool is validated by gynecological oncology surgeons and can be used by trial governance committees as a decision aide for surgeon selection and for ongoing Quality Assurance in surgical clinical trials.

Results in the Context of Published Literature

While local health service protocols(20) suggest specific steps for a sentinel lymph node dissection, the present publication summarizes an operating consensus based on the opinion of a considerable number of international experts in sentinel lymph node dissection. Consensus was achieved about definition of the sentinel node (the node closest to the uterus) regardless of whether it is located at the lateral pelvic wall, the aortic/caval or the presacral area. There was also agreement that the number of sentinel nodes removed should be kept to a minimum. There was no consensus on mandatory need for completion lymphadenectomy on the ipsilateral side of a pelvis that fails to map. This most likely reflects the possibility for patient and uterine factors to indicate against full lymph node dissection. Greater than seventy percent consensus was reached on the need to extract nodes through a containment system, the need for ex-vivo green fluorescence to prove the sentinel node; on specimen labelling and on pathologic ultrastaging.

The competence assessment tool development undertaken in this study follows similar efforts in other surgical specialties. In general surgery, a recent systematic review reporting on Quality Assurance in randomised controlled trials of laparoscopic colorectal surgery identified three distinct categories of surgical Qulaity Assurance measures: (i) trial entry criteria for surgeons and centres; (ii) standardization of surgical techniques; and (iii) continuous monitoring of surgeons and/or units(25). A competence assessment tool was developed, validated and implemented to assess technical surgical performance in the context of a summative assessment process for the National Training Programme in Laparoscopic Colorectal Surgery (Lapco)(28). Subsequently COLOR III(4) investigators have described standardization of surgical interventions followed by development and assessment of objective surgical Quality Assurance tools for use in colorectal trials.

Strengths and Weaknesses

The strengths of our study include the large number of international experts who identified the mandatory, optional and prohibited steps of sentinel lymph node dissection based on consensus. In addition, the competence assessment tool was able to demonstrate contrast validity and internal reliability. Our expert participants reported a range of experience in sentinel lymph node dissection despite recruitment using snowball sampling. We did not use more objective measurements of expertise such as a requirement for study participants to submit their own outcomes data, or videos of their individual technique. Another weakness of our study relates to the impact of our findings on meaningful clinical outcomes such as sensitivity for detection of metastases, or false negative rates. These parameters were not the focus of our study, but we aknowledge the absolute necessity for individual surgeons to monitor their performance including prscopective audit of sensitivity, false negatives, recurrence patterns and rates. This predictive clinical validity of sentinel lymph node dissection technique can only be determined with accumulation of clinical outcomes after using the competence assessment tool in sentinel lymph node dissection clinical trials and educational programs, as has been demonstrated for a colorectal competence assessment tool in the Lapco program (29).

Implications for Practice and Future Research

Despite the benefits of sentinel lymph node dissection, including shorter operating times compared to a lymphadenectomy, it remains unknown in what ways sentinel lymph node dissection impacts clinically relevant outcomes, such as the need for postoperative radiation treatment or chemotherapy, recovery from surgery and quality of life, the incidence of adverse events, disease recurrence and survival(21). Additionally, whilst new surgical procedures may appear promising, there remains a need to evaluate novel surgical procedures for safety and effectiveness(30). Such surgical trials rely on the standardized delivery of the intervention (with minimal variation) to allow a meaningful and reliable comparison between intervention and control groups across multiple surgeons or trial sites. In the context of sentinel lymph node dissection, variability in technique and failure to identify sentinel nodes could translate into the need for frozen section assessment of the uterus, acceptance of unknown nodal status, or may increase the risk of an “empty package”(31), all of which may confound the results of sentinel lymph node dissection efficacy trials. Depending on local protocols, some patients may even require re-staging, a full ipsilateral lymphadenectomy (20), or might warrant adjuvant chemotherapy or radiation treatment based on uterine risk factors. These scenarios may have significant impact on short and long-term patient and trial outcomes. Using this competency assessment tool, institutions or clinical trialists can define quality standards of sentinel lymph node dissection and measure individual surgical performance.

Significant efforts are made by chief investigators and trial management committees to minimize variability in surgical technique and outcomes, including limiting the trial to sites with a high surgical volume. Recently, principal investigators completed a site visit and all surgeons were observed in-person(18, 32) or unedited videos were reviewed to confirm standardization of the technique(33). In other trials, participating surgeons were required to have completed a minimum number of procedures, before the initiation of enrollment(34). While these measures were valuable within institutions, volume, minimal number or observation of one surgery may be inaccurate without application of a standardized assessment tool.

Conclusion

The output from this work includes a list of mandatory and prohibited steps of a sentinel lymph node dissection that independent assessors can use to check for both surgical proficiency as well as whether sentinel lymph node dissection has been performed in accordance to an agreed standard. The work provides specific steps of sentinel lymph node dissection, and the Quality Assurancecriteria developed as part of this process will help with selection of prospective surgeons into surgical trials evaluating sentinel lymph node dissection. The goal is to shorten the learning curve(34) but also to control for heterogeneity in surgical performance that could override the true efficacy(4).

Supplementary Material

Supp1
Supp2

ACKNOWLEDGMENTS

We thank all participants for their expertise in developing this tool. We also thank Vanessa Behan, Queensland Centre for Gynaecological Cancer Research, University of Queensland, Centre for Clinical Research, QLD Australia for administrative support with the project. All those acknowledged have nothing to disclose.

Footnotes

DISCLOSURE STATEMENT COMPETING INTERESTS

Andreas Obermair reports grants and personal fees from SurgicalPerformance PTY LTD, grants from Medtronic, outside the submitted work;

Nadeem Abu-Rustum reports grants from Stryker/Novadaq, outside the submitted work;

Michael Frumovitz reports grants from Astra Zeneca, grants from Tesaro/GSK, grants and personal fees from Stryker, grants from Biom’Up, outside the submitted work;

Mario Leitao reports other from Intuitive Surgical, other from Ethicon, partial grant support from NIH/NCI Memorial Sloan Kettering Cancer Center Support, outside the submitted work;

Thomas Ind reports personal fees from Medtronic, personal fees from Intuitive surgical, outside the submitted work;

Rainer Kimmig reports personal fees from Intuitive Surgical Inc., personal fees from Medtronic, personal fees from Medicaroid, outside the submitted work; and President of SERGS and Council Member of IGCS;

Henrik Falconer reports personal fees from Intuitive Surgical Inc, outside the submitted work;

Jan Persson reports personal fees from Intuitive surgical, outside the submitted work;

Alon Altman reports grants and other from Astrazeneca, other from GSK, grants and other from Merck, other from Sanofi, grants from Pfizer, grants from Clovis, grants from CancerCare Manitoba Foundation, grants from Canadian Clinical Trials group, outside the submitted work;

All other authors declare they have nothing to disclose.

TRIAL REGISTRATION

N/A

PREVIOUS PRESENTATIONS

N/A

DATA ACCESS, RESPONSIBILITY AND ANALYSIS

Kristen Moloney had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

References

  • 1.Cook JA. The challenges faced in the design, conduct and analysis of surgical randomised controlled trials. Trials 2009;10:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ergina PL, Cook JA, Blazeby JM, et al. Challenges in evaluating surgical innovation. Lancet 2009;374:1097–104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Simon C, Caballero C, Gregoire V, et al. Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 ‘Best of’ and 24954 ‘larynx preservation’ study. Eur J Cancer 2018;103:69–77. [DOI] [PubMed] [Google Scholar]
  • 4.Tsai AY-C, Mavroveli S, Miskovic D, et al. Surgical quality assurance in COLOR III: standardization and competency assessment in a randomized controlled trial. Ann Surg 2019;270:768–74. [DOI] [PubMed] [Google Scholar]
  • 5.Claassen YHM, de Steur WO, Hartgrink HH, et al. Surgicopathological quality control and protocol adherence to lymphadenectomy in the CRITICS Gastric Cancer Trial. Ann Surg 2018;268:1008–13. [DOI] [PubMed] [Google Scholar]
  • 6.Harris A, Butterworth J, Boshier PR, et al. Development of a reliable surgical quality assurance system for 2-stage esophagectomy in randomized controlled trials. Ann Surg 2020. doi: 10.1097/SLA.0000000000003850. [Epub ahead of print: 27 Mar 2020]. [DOI] [PubMed] [Google Scholar]
  • 7.Markar SR, Wiggins T, Ni M, et al. Assessment of the quality of surgery within randomised controlled trials for the treatment of gastro-oesophageal cancer: a systematic review. Lancet Oncol 2015;16:e23–31. [DOI] [PubMed] [Google Scholar]
  • 8.Amant F, Mirza MR, Koskas M, et al. Cancer of the corpus uteri. Int J Gynaecol Obstet 2015;131 Suppl 2:S96–104. [DOI] [PubMed] [Google Scholar]
  • 9.de Boer SM, Powell ME, Mileshkin L, et al. Adjuvant chemoradiotherapy versus radiotherapy alone in women with highrisk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. Lancet Oncol 2019;20:1273–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825–32. [PubMed] [Google Scholar]
  • 11.Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987;60:2035–41. [DOI] [PubMed] [Google Scholar]
  • 12.Mikuta JJ. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988: FIGO staging of endometrial cancer. Cancer 1993;71:1460–3. [DOI] [PubMed] [Google Scholar]
  • 13.Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707–16. [DOI] [PubMed] [Google Scholar]
  • 14.Kitchener H, Swart AMC, group Astudy, et al. , ASTEC Swart group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.National comprehensive cancer network practice guidelines in oncology: uterine neoplasms 2020.
  • 16.Rossi EC. Current state of sentinel lymph nodes for women with endometrial cancer. Int J Gynecol Cancer 2019;29:613–21. [DOI] [PubMed] [Google Scholar]
  • 17.Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol 2009;113:163–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017;18:384–92. [DOI] [PubMed] [Google Scholar]
  • 19.Casarin J, Multinu F, Abu-Rustum N, et al. Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists. Int J Gynecol Cancer 2019;29:60–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Holloway RW, Abu-Rustum NR, Backes FJ, et al. Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol 2017;146:405–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Obermair A, Abu-Rustum NR. Sentinel lymph node mapping in endometrial cancer – areas where further research is needed. Int J Gynecol Cancer 2020;30:283–4. [DOI] [PubMed] [Google Scholar]
  • 22.Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 2014;67:401–9. [DOI] [PubMed] [Google Scholar]
  • 23.Harris PA, Taylor R, Minor BL, et al. The REDCap Consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Foster JD, Mackenzie H, Nelson H, et al. Methods of quality assurance in multicenter trials in laparoscopic colorectal surgery: a systematic review. Ann Surg 2014;260:220–9. [DOI] [PubMed] [Google Scholar]
  • 26.Sprangers MA, Cull A, Bjordal K, et al. The European Organization for Research and Treatment of Cancer. approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on quality of life. Qual Life Res 1993;2:287–95. [DOI] [PubMed] [Google Scholar]
  • 27.Miskovic D, Ni M, Wyles SM, et al. Is competency assessment at the specialist level achievable? A study for the National Training Programme in laparoscopic colorectal surgery in England. Ann Surg 2013;257:476–82. [DOI] [PubMed] [Google Scholar]
  • 28.Curtis NJ, Foster JD, Miskovic D, et al. Association of surgical skill assessment with clinical outcomes in cancer surgery. JAMA Surg 2020;155:590–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Cook JA, McCulloch P, Blazeby JM, et al. IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 2013;346:f2820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Harold JA, Uyar D, Rader JS, et al. Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer. Int J Gynecol Cancer 2019;29:53–9. [DOI] [PubMed] [Google Scholar]
  • 31.Janda M, Gebski V, Davies LC, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on diseasefree survival among women with stage I endometrial cancer: a randomized clinical trial. JAMA 2017;317:1224–33. [DOI] [PubMed] [Google Scholar]
  • 32.Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med 2018;379:1895–904. [DOI] [PubMed] [Google Scholar]
  • 33.Frumovitz M, Plante M, Lee PS, et al. Near-Infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, noninferiority trial. Lancet Oncol 2018;19:1394–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cusimano MC, Walker R, Bernardini MQ, et al. Implementing a cervical sentinel lymph node biopsy program: quality improvement in gynaecologic oncology. J Obstet Gynaecol Can 2017;39:659–67. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp1
Supp2

RESOURCES